Skip to main content
Erschienen in: Journal of Gastroenterology 4/2020

08.02.2020 | Letter to the Editor

Statins and pancreatic cancer risk

verfasst von: Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

Erschienen in: Journal of Gastroenterology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

Statins are used to treat hypercholesterolemia, but they have a potential effect on cancer risk. The correlation between statins use and pancreatic cancer risk has been examined in different study populations. A cohort study in Taiwan reported that statins users among patients with type 2 diabetes had a lower incidence rate of pancreatic cancer comparing with non-users (incidence rate ratio 0.46) [1]. Two prospective cohort studies in USA conducted by Hamada et al. published in Journal of Gastroenterology reported that statins use was not statistically associated with the risk of pancreatic cancer in the general population (adjusted odds ratio 0.98 and 95% confidence interval 0.82–1.16) [2]. Their findings were compatible with a case–control study in Taiwan showing that statins use was not statistically associated with the risk of pancreatic cancer in the general population (adjusted odds ratio 0.87 and 95% confidence interval 0.56–1.36) [3]. …
Literatur
1.
Zurück zum Zitat Chen MJ, Tsan YT, Liou JM, et al. Statins and the risk of pancreatic cancer in type 2 diabetic patients—a population-based cohort study. Int J Cancer. 2016;138:594–603.CrossRef Chen MJ, Tsan YT, Liou JM, et al. Statins and the risk of pancreatic cancer in type 2 diabetic patients—a population-based cohort study. Int J Cancer. 2016;138:594–603.CrossRef
2.
Zurück zum Zitat Hamada T, Khalaf N, Yuan C, et al. Statin use and pancreatic cancer risk in two prospective cohort studies. J Gastroenterol. 2018;53:959–66.CrossRef Hamada T, Khalaf N, Yuan C, et al. Statin use and pancreatic cancer risk in two prospective cohort studies. J Gastroenterol. 2018;53:959–66.CrossRef
3.
Zurück zum Zitat Chiu HF, Chang CC, Ho SC, et al. Statin use and the risk of pancreatic cancer: a population-based case–control study. Pancreas. 2011;40:669–72.CrossRef Chiu HF, Chang CC, Ho SC, et al. Statin use and the risk of pancreatic cancer: a population-based case–control study. Pancreas. 2011;40:669–72.CrossRef
5.
Zurück zum Zitat Lai SW, Lin CL, Chang Ou KC, et al. Association between acute pancreatitis and pancreatic cancer. Eur J Gastroenterol Hepatol. 2019;31:896–7.CrossRef Lai SW, Lin CL, Chang Ou KC, et al. Association between acute pancreatitis and pancreatic cancer. Eur J Gastroenterol Hepatol. 2019;31:896–7.CrossRef
6.
Zurück zum Zitat Kirkegard J, Lund JL, Mortensen FV, et al. Statins and pancreatic cancer risk in patients with chronic pancreatitis: a Danish nationwide population-based cohort study. Int J Cancer. 2020;146:610–6.CrossRef Kirkegard J, Lund JL, Mortensen FV, et al. Statins and pancreatic cancer risk in patients with chronic pancreatitis: a Danish nationwide population-based cohort study. Int J Cancer. 2020;146:610–6.CrossRef
7.
Zurück zum Zitat Bang UC, Watanabe T, Bendtsen F. The relationship between the use of statins and mortality, severity, and pancreatic cancer in Danish patients with chronic pancreatitis. Eur J Gastroenterol Hepatol. 2018;30:346–51.CrossRef Bang UC, Watanabe T, Bendtsen F. The relationship between the use of statins and mortality, severity, and pancreatic cancer in Danish patients with chronic pancreatitis. Eur J Gastroenterol Hepatol. 2018;30:346–51.CrossRef
Metadaten
Titel
Statins and pancreatic cancer risk
verfasst von
Shih-Wei Lai
Yu-Hung Kuo
Kuan-Fu Liao
Publikationsdatum
08.02.2020
Verlag
Springer Singapore
Erschienen in
Journal of Gastroenterology / Ausgabe 4/2020
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-020-01675-x

Weitere Artikel der Ausgabe 4/2020

Journal of Gastroenterology 4/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.